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propionate, and butyrate are formed in the human colon at a ratio of about 3:1:1 (38,39). In an in vivo study, the rate of SCFAs release by the gut to the circulatory system amounts to about 35 µmol/kg body weight/h (40). The highest concentrations (70-140 mM) were found in the proximal colon (2) .
SCFAs may contribute to approximately 10% of the total human caloric uptake (4) .
For newborn mammals, including human babies, mother's milk constitutes an important source of MCFAs and SCFAs that are present mainly in the form of triglycerides and phospholipids.
For example, the content of MCFAs (C 7:0 -C 12:0 ) amounts to 6% -17% and to 9% -28% of all fatty acids in bovine (1) SCFAs and MCFAs can also be formed in mammalian and human tissues, mainly liver. Thus, the peroxisomal β-oxidation of LCFAs produces chain-shortened acyl-CoAs (43) that can be hydrolyzed inside peroxisomes by distinct acyl-CoA thioesterases and released into the cytosol. In addition, peroxisomes are also equipped with carnitine-acetyl and carnitine-octanoyl transferases and thus shortened acyl-CoAs are converted into carnitine esters for the supply to mitochondria [reviewed in (44)].
Under pathological conditions, for example in inborn medium-chain acyl-CoA dehydrogenase deficiency, octanoate and decanoate accumulate to considerable amounts in tissues (45) resulting in an impairment of functioning of the mitochondrial respiratory complexes (46). These disorders are often accompanied by elevated urinary excretion of dicarboxylic MCFAs (mainly adipic, suberic and sebacic acids) that apparently originate from microsomal ω-oxidation of corresponding medium-chain acyl-CoAs (47,48). Based on their rapid absorption, triglycerides of MCFAs were introduced as a quickly available energy source in clinical nutrition in the middle of the last century. Emulsions enriched with MCFA-containing triglycerides were applied to patients suffering from various forms of impaired digestion of normal LCFA-containing triglycerides (1) . In addition, due to the rapid transport by guest, on October 14, 2017 www.jlr.org
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of MCFAs from the gut to the liver, breath tests were developed for non-invasive clinical diagnosis using 13 C-labeled octanoate (49,50). Thereby, specific hepatic pathways as well as the speed of gastric emptying can be measured [reviewed in (51)].
PRINCIPLES OF METABOLISM IN ANIMAL TISSUES

Transport from the gut to the liver
Butyrate is taken up by enterocytes presumably by means of the monocarboxylate transporter 1 (MCT-1) and the sodium-coupled monocarboxylate transporter 1 (SMCT-1) [reviewed in (52,53)].
Butyrate is used by these cells mostly as fuel. According to other authors, SCFAs are also absorbed from the intestine lumen by an exchange with Cl¯ (54) and/or HCO 3¯ (55). More recently, however, the non-ionic diffusion of protonated SCFAs and MCFAs across the colon epithelium has been favored (56). The latter mechanism is also supported by studies in model systems (30). According to this mechanism the intestinal absorption of SCFAs depends on pH, while slight acidification of luminal pH, possibly by bacterial metabolic activity, increases the prevalence of the protonated form of SCFAs. Otherwise, the transport of SCFAs from enterocytes into the blood might be driven by anion exchange. Thus, it seems likely that the transport across the basolateral membrane is based on the anionic form of SCFAs against HCO 3¯ (57). Butyrate as well as other SCFAs and MCFAs that have not been utilized by enterocytes are transported by the portal vein to liver (40,58) and metabolized by hepatocytes.
In contrast to LCFAs, which are esterified to triglycerides in enterocytes, incorporated into chylomicrons and then enter the lymphatic system, SCFAs and MCFAs from the intestinal tract enter the portal vein as free acids. There, MCFAs become partly bound to plasma albumin. The proportion between albumin-bound and free MCFAs increases with increasing chain length, so that the first equilibrium constant (i.e. for the strongest binding site) between the albumin-bound and the free forms increases from 1.5 x 10 4 for hexanoate, through 3. (63) . Interestingly, in rats deficient in one of the fatty acid transport proteins (CD36 protein), feeding with SCFA-and MCFArich diet eliminated the increased glucose uptake, hyperinsulinemia and heart hypertrophy (64) .
Similarly, in CD36-deficient mice octanoate alleviated poor heart ischemic tolerance (65) . These observations may have important implications to human medicine.
Fuelling the tissue energy metabolism
The utilization by different tissues of acetate formed by intestinal bacteria greatly differs between ruminants and non-ruminants [(4) and references therein]. Acetate is also endogenously generated in adult humans by ethanol oxidation, which operates mainly in liver (66) . Thus, it has been shown that ethanol oxidation could result in a 20-fold increase of the acetate level in peripheral blood (67) . In addition, net acetate generation has been found during fatty acid oxidation in perfused rat liver (68) . Formed acetate results mainly from the operation of acetyl-CoA hydrolase (acetyl-CoA deacylase), which in rat liver has been found predominantly in the mitochondrial matrix (69, 70) .
Because acetyl-CoA hydrolase is inhibited by free CoASH (K i =17 µM), the level of free CoASH has to be strongly lowered before hydrolase can produce free acetate from acetyl-CoA (70) . On the other hand, free acetate produced in liver by oxidation of ethanol or as byproduct of ketogenesis is barely oxidized in this organ. This is because of high K m of hepatic mitochondrial acetyl-CoA synthetase (71) or its absence in these organelles [(72) transported by circulation to other organs, e.g. the heart and skeletal muscles, where K m of mitochondrial acetyl-CoA synthetase is much lower and where it can be utilized as fuel (70) .
Activation of SCFAs occurs in the liver and several other tissues by acyl-CoA synthetases (72) .
These enzymes are located in the cytosol as well as in the mitochondrial matrix, where they are loosely bound to the inner mitochondrial membrane. In mammals, acetate is activated to acetyl-CoA by two different acetyl-CoA synthetases, of which one (AceCS1) is cytosolic (78 kDa, K m =0.11 mM) and the other one (AceCS2) mitochondrial (71 kDa, K m =0.06) (73) . According to these authors (73),
AceCS2 is present in a wide range of tissues, with the highest level in heart (bovine and rodent), but essentially absent in liver. In contrast, earlier investigations (74) (75) (76) demonstrated the presence of acetyl-CoA synthetase activity in hepatocytes in both mitochondria (20-50%) and the cytosol (50-80%).
Acetate is an important fuel during fasting as evidenced by the observation that in skeletal muscles of mice lacking AceCS2 the ATP content declined to 50% in comparison to wild-type mice (77 Energization by octanoate of hepatocytes oxidizing pyruvate plus lactate was also manifest (100).
However, in contrast to LCFAs (e.g. oleate), octanoate significantly raised the AMP level in the tissue (89,100). It has also been reported that feeding rats with MCFA-rich diet enhances skeletal muscle mitochondrial oxidative capacity (62,103), an observation which is partly attributed to an increased activity of citrate synthase (62).
Because MCFA-containing triglycerides are rapidly digested in the intestine, rapidly taken up by enterocytes and are not incorporation into chylomicrons, they are ideal energy-delivering nutrients in clinical situations, where the digestion and/or absorption of LCFA-containing triglycerides is impaired or a rapid energy uptake by the body is required. For this reason, MCFA-containing triglycerides have been used for the nutrition of patients with inherited LCFA β-oxidation disorders (104) . While increasing evidence indicates that the diseased heart suffers from energy deficiency, fuelling the myocardial energy metabolism with MCFAs has been proposed as metabolic therapy for treating patients suffering from certain cardiomyopathies (87). For this treatment, MCFAs with odd carbon-atom numbers appeared superior compared to those with even carbon-atom numbers (105) .
Modulation of carbohydrate and lipid metabolism
Contrary to LCFAs, the oxidation of MCFAs is not affected by the carbohydrate content in the diet. Thus, it has been reported that adaptation of adult rats to low-fat high-carbohydrate or high-fat low-carbohydrate diet does not change the rate of octanoate oxidation measured in hepatocytes. In contrast, oleate oxidation declined by 50% in rats adapted to low-fat high-carbohydrate diet (61).
Furthermore, MCFAs derived from digestion of MCFA-containing triglycerides are predominantly degraded by the hepatic mitochondrial β-oxidation. Excess of formed acetyl-CoA is used for the synthesis of ketone bodies (mostly acetoacetate and β-hydroxybutyrate), which are delivered as fuel to non-hepatic tissues (21,22). MCFA-containing triglycerides are preferentially hydrolyzed compared to those containing LCFAs and liberated MCFAs are also preferentially oxidized in organs, mostly heart, muscles, kidneys, and liver (93, 106 Generally, it has been discussed that mitochondrial matrix enzymes, pyruvate carboxylase and the pyruvate dehydrogenase complex, are regulated by the ratios of acetyl-CoA/CoA, ATP/ADP and NADH/NAD + and, in addition, by pyruvate concentration. On the other hand, however, the fatty acid (octanoate, palmitate)-induced increase of pyruvate flux through both enzymes has been explained exclusively by an increased uptake of pyruvate into the mitochondrial matrix compartment (109, 111) .
It has been argued that the formation of acetoacetate from fatty acids drives pyruvate uptake across the inner mitochondrial membrane. Therefore, there is reason to hypothesize that SCFAs and MCFAs play a supporting role in the utilization of physiological low concentrations of pyruvate or lactate for glucose generation (104) . Nevertheless, acceleration of pyruvate uptake is not sufficient to explain the huge stimulation by fatty acids of glucose generation with aspartate plus glycerol as gluconeogenic precursors (110) . Such stimulation is generally attributed to the generation of acetyl-CoA (allosteric effector of pyruvate carboxylase) and reducing equivalents (114), the latter promoting formation of glyceraldehyde-3-phosphate. It is also worthy to remember that pyruvate carboxylation in isolated rat liver mitochondria is strongly stimulated by L-octanoylcarnitine, whereas non-esterified butyrate and octanoate exert a strong inhibition (100). In addition, octanoate exerts a short-term dual regulatory effect on the hepatic fatty acid synthesis, namely stimulation in the low concentration range (up to 1 mM) and inhibition at higher concentrations (107, 112) . excited and thereby release increased amounts of glutamate (124, 125) . It is assumed that glutamate release is likely to decrease the level of citric acid cycle metabolites and thereby declines the oxidation of acetyl-CoA by mitochondria. Indeed, it has been recently shown that triheptanoin partially restores the level of citric acid cycle metabolites in an epileptic animal model (126) . Triheptanoin is also able to attenuate harmful side effects associated with ischemic stroke (127) . For illustration, when mice were exposed to transient ischemia, triheptanoin reduced the extracellular level of glutamate released in the mouse striatum, maintained the cellular ATP content at the desired level and prevented a decline of the respiratory activity of isolated brain mitochondria. The latter findings strongly suggest that the mitochondrial ATP regeneration is a target of the trihepatoin action (127) . It is also worthwhile to mention that, in sharp contrast to butyrate and octanoate, the odd-chain SCFA propionate has no inhibitory effect on glycolysis and does not stimulate ketogenesis (108) . Similarly to propionyl-CoA formed by the cellular degradation of odd-chain fatty acids, external propionate supplies the gluconeogenic pathway with its hydrocarbon skeleton, an activity that is mostly observed in ruminants
[reviewed in (128) ].
POTENTIAL ADVERS EFFECTS
Energy coupling
LCFAs are long known as mild uncouplers of oxidative phosphorylation due to their protonophoric effect on the inner mitochondrial membrane [reviewed in (23)]. The mechanism of this effect has been comprehensively explained by Skulachev (129, 130) who showed that LCFA anions can be transferred across the inner mitochondrial membrane by adenine nucleotide translocase, whereas the non-dissociated fatty acid molecules can move across the membrane by flip-flop mechanism. As effect, a net proton transfer occurs. Subsequent studies have shown that LCFA anions can also be transferred across the mitochondrial inner membrane by a number of other mitochondrial inner membrane anion carriers [reviewed in (131, 132) ]. This protonophoric effect decreases the electrochemical proton gradient across the inner membrane, thereby decreasing the efficiency of oxidative phosphorylation. (139) (140) (141) . In the case of acetate this cycling is likely to occur in the cytoplasm of hepatocytes and may account for as much as 1% of the total heat production (141).
Butyrate and octanoate are known to stimulate oxygen uptake in perfused liver and isolated hepatocytes, to raise the energization of mitochondria and to support ATP-dependent glucose generation (100,101,109). However, it has been repeatedly observed that these two fatty acids increase oxygen uptake and dramatically lower the ATP/O ratio when added to the incubation or perfusion media supplemented with pyruvate plus lactate or lactate alone (89,96,97,100), thus pointing to an impairment of the energy generation. The mechanism of this effect could not be explained by protonophoric uncoupling of oxidative phosphorylation by these SCFAs and MCFAs, as the latter was characteristic for LCFAs (see the preceding chapter). The main argument against such a mechanism was the observation that oligomycin, a well known inhibitor of mitochondrial ATPase/ATP synthase, abolished most of the enhanced hepatic oxygen consumption (89,99) as well as the octanoatestimulated oxygen uptake by isolated rat liver mitochondria (100). Other authors attributed the impairment of energy metabolism by butyrate and octanoate to the stimulation of Na +/ K + -ATPase (99) or to an increase in the FADH 2 /NADH ratio due to β-oxidation (96) . However, these explanations seem unlikely since a similarly enhanced oxygen uptake in the presence of LCFAs was not sensitive to oligomycin. A further clue seemed to be a stationary elevated AMP level, which was not observed with LCFAs (89,100,142-144). This pointed to an increased turnover of ATP within mitochondria rather than to its impaired production. In addition, this putative ATP turnover competed with intramitochondrial ATP-dependent reactions, i.e., pyruvate carboxylation (100) and citrulline synthesis (144). We have shown (100) that this phenomenon is due to enhanced activation of octanoate within the inner mitochondrial compartment, accompanied by utilization of two high-energy bonds per each molecule of octanoyl-CoA formed. Because both octanoyl-AMP and octanoyl-CoA could be partly hydrolyzed within the mitochondrial matrix, a futile cycle appeared that was responsible for the increased intramitochondrial ATP consumption that resulted in lowering the mitochondrial membrane potential and thus increasing oxygen uptake (Fig. 1 ). This mechanism may prevent a drastic depletion of intramitochondrial free CoA under high supply of SCFAs and MCFAs with the portal vein. In addition, the octanoate activation-associated increased AMP level decreases the intramitochondrial pool of exchangeable adenine nucleotides ATP and ADP, an event that slows down the operation rate of the adenine nucleotide translocase and thereby enhances the control strength of this transporter on the total flux of oxidative ATP generation (145) .
These specific properties of SCFAs and MCFAs may explain the well-known facts that diets rich in these fatty acids increase energy expenditure and decrease adiposity (146) (147) (148) 
Generation of reactive oxygen species
Oxygen consumption by mitochondria is accompanied by the generation of reactive oxygen species (ROS), of which β-oxidation is the most important source (154) (155) (156) (157) . Theoretically, a oneelectron transfer to molecular oxygen, thereby forming superoxide, can take place from complex I of the respiratory chain as well as from acyl-CoA dehydrogenase, the electron transfer flavoprotein (ETF), the ETF-ubiquinone oxidoreductase, and complex III (Fig. 2 , more details are given in the legend). Indeed, it has been demonstrated for skeletal muscle mitochondria that several sites are involved in the β-oxidation-linked superoxide generation (158) . H 2 O 2 release by mitochondria from (rat) skeletal muscle, heart, and liver was measured with carnitine derivatives of palmitate, octanoate, and butyrate as substrates (157, 159) . These studies have shown that the β-oxidation-associated ROS generation is similar with LCFAs and MCFAs (157, 159) . In contrast, it has been reported that C2C12 myotubes treated with capric (C 10 ) or lauric (C 12 ) acid generate less ROS than treated with LCFAs myristic or palmitic acid, whereas the oxygen consumption is higher with MCFAs than with LCFAs (149). These authors speculate that this decrease in ROS production might be attributed to an increased expression of uncoupling protein-3 by MCFAs. However, other authors (160) did not observe increased expression of uncoupling protein-3 in hearts of rats fed MCFA-rich diet.
Along with their direct role in ROS generation as electron donors to the respiratory chain in β-oxidation, fatty acids also play an indirect effect on superoxide production due to modifying both the rate of the electron flux along the respiratory chain and the degree of energy coupling. As discussed by ourselves in detail elsewhere (161) thus producing an uncoupling-like effect. In addition, both acyl-AMP and acyl-CoA are subject to slow hydrolysis thus increasing AMP production and futile energy utilization. 
